|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
; R1 }1 V, E9 g8 D- h% o' l0 J9 ]% f8 F r
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
: p7 ?/ q% s0 R- }
8 Y& F& C* j( v& _头颈肿瘤BU入选ASCO 2025的研究
# x/ x: n) }2 `* G4 aHot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.7 {! K! M6 S. h/ ]; [
肿瘤内科-头颈肿瘤科姜愚团队 k1 ]! m7 P. Y( E3 Z/ c7 ^
$ ]& v/ H5 x4 \0 n# M
Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.9 v. R! V- N9 w/ L# p2 _- d% L
肿瘤内科-头颈肿瘤科刘磊团队) s4 Y Q: r9 O8 y# ~) j2 e+ Y
' Z# G" g7 k( W/ M# P
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.6 n8 d0 Z B' a% W% d6 M+ T4 B
肿瘤内科-头颈肿瘤科刘磊团队
4 B* L6 x+ W, l) c' ?6 ~( f! Q! b: `$ m
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
2 w9 Y2 ^$ H1 Y' v肿瘤内科-头颈肿瘤科刘磊团队, ?3 J$ I) A2 D2 i3 W
- E7 O6 I. D) [8 f2 ]! G
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
5 J" Y f7 }2 j肿瘤内科-头颈肿瘤科姜愚团队9 m3 e, }7 `" f3 |
|
|
[复制链接]
发表于 2025-5-2 09:58:22
